DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced a strategically focused expansion of its neurology pipeline with the acquisition of the rights to ...
- Merck to accelerate development of Chord's innovative pipeline for generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD) - Focused expansion in neuroinflammatory ...
Geneva, December 20, 2021: Chord Therapeutics (Chord), a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, today announces that it is being acquired by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback